Diabetes Research Institute Successfully Transplants BioHub in First Patient

0
0
384 days ago, 893 views
The Diabetes Research Institute or DRI announced that the first patient in its BioHub clinical trial to test for the first time a novel transplant technique for insulin-producing cells was successfully completed. This FDA-approved Phase I/II study builds upon decades of progress in islet transplantation and is an important first step toward the development of the DRI BioHub, a bioengineered mini-organ that will mimic the native pancreas to restore natural insulin production in people with type 1 diabetes. Watch the video and meet the first patient and learn more about the clinical trial in this latest episode of DRI tv.

SPONSORS

No comments found.

SPONSORS